{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:05Z","timestamp":1761630605260},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1331,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1365-2230.2011.04289.x","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T10:42:34Z","timestamp":1326105754000},"page":"572-573","source":"Crossref","is-referenced-by-count":6,"title":["Skin fragility and blistering secondary to imatinib"],"prefix":"10.1093","volume":"37","author":[{"given":"H.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. L.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Maung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,9]]},"reference":[{"key":"10.1111\/j.1365-2230.2011.04289.x-BIB1|cit1","first-page":"228","article-title":"Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate","volume":"5","author":"Scheinfeld","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2230.2011.04289.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2141.2003.04151_4.x","article-title":"A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (sti 571, Glivec\u00ae)","volume":"120","author":"Drummond","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2230.2011.04289.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM200108233450814","article-title":"Cutaneous reactions to STI571","volume":"345","author":"Brouard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2230.2011.04289.x-BIB4|cit4","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-08-2431","article-title":"Managing cutaneous reactions to imatinib therapy","volume":"100","author":"Rule","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1365-2230.2011.04289.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2003-08-2869","article-title":"Treatment with cyclosporine a cream for the cutaneous reactions associated with imatinib therapy","volume":"105","author":"Schamun","year":"2005","journal-title":"Blood"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2011.04289.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2011.04289.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:10:26Z","timestamp":1676383826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/37\/5\/572\/6622797"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2012,1,9]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04289.x","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,9]]}}}